Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults

Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults

Background: An acellular Pertussis (aP) vaccine containing recombinant genetically detoxified Pertussis Toxin (PTgen), Filamentous Hemagglutinin (FHA) and Pertactin (PRN) has been developed by BioNet-Asia (BioNet). We present here the results of the first clinical study of this recombinant aP vaccin...

Full description

Bibliographic Details
Main Authors: Chukiat Sirivichayakul, Pornthep Chanthavanich, Kriengsak Limkittikul, Claire-Anne Siegrist, Wassana Wijagkanalan, Pailinrut Chinwangso, Jean Petre, Pham Hong Thai, Mukesh Chauhan, Simonetta Viviani
Format: Article
Language:English
Published: Taylor & Francis Group 2017-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
clinical trial
phase i/ii
thailand
recombinant acellular pertussis vaccine
tdap
Online Access:http://dx.doi.org/10.1080/21645515.2016.1234555

Internet

http://dx.doi.org/10.1080/21645515.2016.1234555

Similar Items